16-Methoxytabersonine
![]()  | |
| Names | |
|---|---|
| IUPAC name  Methyl 16-methoxy-2,3,6,7-tetradehydro-5α,12β,19α-aspidospermidine-3-carboxylate   | |
| Systematic IUPAC name  Methyl (3aR,3a1S,10bS)-3a-ethyl-8-methoxy-3a,3a1,4,6,11,12-hexahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate  | |
| Other names  Ervamycine   | |
| Identifiers | |
3D model (JSmol)   |  |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| KEGG | |
PubChem CID   |  |
| UNII | |
CompTox Dashboard (EPA)   |  |
  | |
  | |
| Properties | |
| C22H26N2O3 | |
| Molar mass | 366.461 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).   Infobox references   | |
16-Methoxytabersonine is a terpene indole alkaloid produced by the medicinal plant Catharanthus roseus. 16-methoxytabersonine is synthesized by methylation of the hydroxyl group at the 16 position of 16-hydroxytabersonine by tabersonine 16-O-methyltransferase (16OMT).[1] The compound is a substrate for hydration by two concerted enzymes Tabersonine-3-Oxidase (T3O) and Tabersonine-3-Reductase (T3R), which leads to the formation of 3-hydroxy-16-methoxy-2,3-dihydrotabersonine.[2]
References
- ^ Levac, Murata, Kim and De Luca (2008) Application of carborundum abrasion for investigating the leaf epidermis: molecular cloning of Catharanthus roseus 16-hydroxytabersonine-16-O-methyltransferase. The Plant Journal. 53(2). 225-236
 - ^ Qu, Y., Easson, M. L., Froese, J., Simionescu, R., Hudlicky, T., & De Luca, V. (2015). Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast. Proceedings of the National Academy of Sciences, 112(19), 6224-6229.
 
